1995
DOI: 10.1016/0169-328x(95)00035-q
|View full text |Cite
|
Sign up to set email alerts
|

Calbindin D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer disease subjects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
13
0

Year Published

1995
1995
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(15 citation statements)
references
References 16 publications
2
13
0
Order By: Relevance
“…Additionally, both probes for calbindin revealed significant decreases (85% and 86%) in hippocampal tissue from AD brains compared with tissue from aged controls brains (data not shown). These findings are in accordance with the idea that calbindin immunoreactivity is reduced in the hippocampus with AD and correlates with pathology, and cognitive impairment (Iritani et al, 2001; Maguire-Zeiss et al, 1995; Palop et al, 2003). On the whole, our results underscore the extent of age-related changes in calcium handling and lend credence to the calcium hypothesis of Alzheimer's disease.…”
Section: Discussionsupporting
confidence: 92%
“…Additionally, both probes for calbindin revealed significant decreases (85% and 86%) in hippocampal tissue from AD brains compared with tissue from aged controls brains (data not shown). These findings are in accordance with the idea that calbindin immunoreactivity is reduced in the hippocampus with AD and correlates with pathology, and cognitive impairment (Iritani et al, 2001; Maguire-Zeiss et al, 1995; Palop et al, 2003). On the whole, our results underscore the extent of age-related changes in calcium handling and lend credence to the calcium hypothesis of Alzheimer's disease.…”
Section: Discussionsupporting
confidence: 92%
“…In Alzheimer’s disease, reductions in the number of Calb1-containing neurons were observed in the hippocampal CA2 subfield [18] and various isocortical regions [13] in a layer-specific fashion [11]. In Parkinson’s disease, Calb1-immunoreactive subpopulations of dopaminergic neurons residing in the dorsal substantia nigra pars compacta and ventral tegmental area were relatively spared from degeneration [10, 33].…”
Section: Resultsmentioning
confidence: 99%
“…(67) In some neurons, analogous to the antiapoptotic effect of calbindin-D 28k in lymphocytes, (68) the induction of calbindins by 1,25(OH) 2 D 3 may protect against cell death in the face of repetitive calcium transients, (69) and in fact the expression of calbindin-D 28k mRNA is decreased in the hippocampus of Alzheimer's patients as assessed by in situ hybridization. (70,71) Taken together, these observations not only imply a modulatory role for VDR in neural cell growth and differentiation but also intimate a possible role for 1,25(OH) 2 57) suppression of ␥-interferon (202) and IL-1 through IL-6 (53,159,203) Central nervous system dorsal root ganglia, (204) glial cells, and hippocampus (70,107) production of NGF, (65,66,205) neurotrophin-3, (64) and leukemia inhibitory factor (63) Epithelium epidermal skin/keratinocyte (206) differentiation (17,211) hair follicle (207) differentiation (16,17,212) female reproductive tract (208) uterine development (16) mammary (108) 2 cell growth (213) prostate (209) 2 cell growth (173) colon (210) 2 cell growth (170,214) lung (108) surfactant (215) Endocrine system thyrotrope (216) TRH receptor (218) thyroid (108) 2...…”
Section: Neoclassical 125(oh) 2 D 3 /Vdr Actionsmentioning
confidence: 99%